October 24 - 27, 2024   Radisson Blu Aqua Hotel, Chicago

Agenda

All times listed are Central Time Zone.

Thursday, October 24

8:00 AM Breakfast & Check-in
9:00 AM Welcome
William Gradishar, MD
SESSION 1
Issues in Survivorship
Session Moderator: Patricia Robinson, MD
9:05 AM What’s New in Lymphedema Risk Assessment, Evaluation, and Management?
Sarah McLaughlin, MD
9:35 AM Immediate Lymphatic Reconstruction for Lymphedema Prevention and Treatment
Michelle Coriddi, MD
10:05 AM Survivorship Issues in Young Women
Sheetal Kircher, MD
10:35 AM Breast Screening in Transgender Patients
Sally Friedwald, MD
11:05 AM What’s New in Exercise Oncology
Lee Jones, PhD
11:35 AM Q&A
11:55 AM Lunch
SESSION 2
Breast Pathology for the Non-Pathologist
Session Moderator: Kalliopi Siziopikou, MD, PhD
1:00 PM Artificial Intelligence (AI) applications in Breast Pathology
Lee Cooper, PhD
1:30 PM Spindle Cell Lesions of the Breast
Indu Agarwal, MD
2:00 PM Breast Pathology in Transgender Individuals
Molly Klein, MD
2:30 PM Beyond BRCA: Pathologic Features of Breast Carcinomas Associated with Other Genes Conferring Breast Cancer Risk
Kalliopi Siziopikou, MD, PhD
3:00 PM Q&A
3:20 PM Break
3:40 PM Unusual Cases Panel
Moderator: William Gradishar, MD
5:00 PM Adjourn

View more agendas: Thursday | Friday | Saturday | Sunday

Friday, October 25

7:30 AM Breakfast
SESSION 3
Imaging & Risk
Session Moderator: Seema Khan, MD
8:30 AM Polygenic Risk Scores: Ready for Primetime?
Claudine Isaacs, MD
9:00 AM Genetic Risk Evaluation after Breast Cancer Diagnosis: Promise vs Practice
Steven Katz, MD
9:30 AM AI in Breast Imaging: Where Are We Now?
Emily Conant, MD
10:00 AM Break
10:20 AM Vaccines for Prevention and Treatment
Elizabeth Mittendorf, MD
10:50 AM Q&A
11:10 AM LYNN SAGE DISTINGUISHED LECTURE
TBA
Tim Whelan, MD
12:10 PM Lunch
SESSION 4
Controversies in Hormone Receptor Positive Breast Cancer
Session Moderator: Jonathan Strauss, MD
1:30 PM Ovarian Function Suppression: When is it Indicated?
Karen Gelmon, MD
2:00 PM Current Status of Immunotherapy in HR+ Breast Cancer
Heather McArthur, MD
2:30 PM Is RT Necessary in Postmenopausal HR+ Women at Low Genomic Risk?
Reshma Jagsi, MD
3:00 PM Break
3:20 PM Breast Cancer in Older Women
Christina Minami, MD
3:50 PM Improving Options in HR+ Metastatic Cancer
William Gradishar, MD
4:20 PM Q&A
4:45 PM Adjourn

View more agendas: Thursday | Friday | Saturday | Sunday

Saturday, October 26

7:30 AM Breakfast
SESSION 5
Factors Informing Treatment and Management of Early-Stage Disease
Session Moderator: Janice Lu, MD, PhD
8:30 AM What’s New in DCIS?
Tari King, MD
9:00 AM Radiation Therapy in DCIS: Factors to Consider
Seema Khan, MD
9:30 AM Targeted Therapy and Endocrine Therapy
Fred Howard, MD
10:00 AM Management of the HER2+ Patient in 2024
Charles Geyer, MD
10:30 AM Break
11:00 AM Intensive Surveillance: Is it Warranted?
Pro: Hatem Soliman, MD | Con: Virginia Kaklamani, MD, DSc
11:30 AM Q&A
12:00 PM Lunch
SESSION 6
Tailoring Local Therapy
Session Moderator: Monica Morrow, MD
1:15 PM Phyllodes Tumors
Laura Rosenberger, MD
1:45 PM TILS Today
Sunil Badve, MD
2:15 PM When Can Axillary Staging be Eliminated?
Monica Morrow, MD
2:35 PM When is Axillary Staging Necessary?
Armando Giuliano, MD
2:55 PM Q&A
3:25 PM Case Management Panel
Moderator: Monica Morrow, MD. Panel: Armando Giuliano, MD; William Gradishar, MD; Nora Hansen, MD; Virginia Kaklamani, MD, DSc; Jonathan Strauss, MD
5:00 PM Adjourn

View more agendas: Thursday | Friday | Saturday | Sunday

Sunday, October 27

7:30 AM Breakfast
SESSION 7
Questions, Controversies and Future Directions
Session Moderator: Bill Gradishar, MD
8:30 AM Isolated Tumor Cells: Clinical and Prognostic Implications
Andrea Barrio, MD
9:00 AM Radiation Therapy after NAC: NSABP B51
Terry Mamounas, MD
9:30 AM Stage 1 HER2+ and TN Cancer: Surgery First or NAC?
Anita Mamtani, MD
10:00 AM cTDNA: Current Status
Ben Park MD
10:30 AM Q&A
11:00 AM Adjourn

View more agendas: Thursday | Friday | Saturday | Sunday

Breakout

There will be no breakout sessions in 2020


View more agendas: Thursday | Friday | Saturday | Sunday

THE PROGRAM

The Lurie Cancer Center's Lynn Sage Breast Cancer Symposium offers 3 days of formal presentations and interactive Q&A sessions.

FACULTY

The Lynn Sage Breast Cancer Symposium is proud of its tradition of attracting a faculty comprised of experts from around the world. Faculty list

NON-CME EDUCATIONAL ACTIVITIES

Optional, non-CME educational activities are scheduled during times that do not conflict with the Symposium agenda.

Details »

© 2024 Robert H. Lurie Comprehensive Cancer Center